Risk of hepatocellular carcinoma in patients with HBsAg positive
- Author:
Pham Quang Cu
- Publication Type:Journal Article
- Keywords:
hepatocellular carcinoma, HbsAg
- MeSH:
Hepatitis B Surface Antigens;
Carcinoma, Hepatocellular;
Hepatitis B
- From:Journal of Vietnamese Medicine
2003;287(8):7-10
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
This study was conducted from the year 1997 to 2002 in the Hospital N 198, involving 300 patients with HBsAg (+) (Group A) and 150 patients with HBsAg (-) (Group B), all had liver and bile pathology. There were an analogy in age, gender, and the time of onset of clinical symptoms. Results showed that there is an prevalence of epithelial liver carcinoma (15%) in the group of HBsAg (+) higher than the the group of HBsAg (-) – only 5.3%. The risk of liver cancer in HBsAg (+) patient group with OR=3.1, the mean age of liver cancer patient group; the characteristics lower than HBsAg (-) patient group; the characteristics of cancer damage, the complications and the prognosis were analogous in 2 groups
